As of January 23, 2025, Synlogic (SYBX) has a market cap of $16.725 million USD. According to our data, Synlogic is ranked No.8678 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $16.73 M |
2.14%
|
Dec 31, 2024 | $16.37 M |
-63.64%
|
Dec 29, 2023 | $45.03 M |
406.58%
|
Dec 30, 2022 | $8.89 M |
-68.60%
|
Dec 31, 2021 | $28.30 M |
12.04%
|
Dec 31, 2020 | $25.26 M |
-16.28%
|
Dec 31, 2019 | $30.18 M |
-63.20%
|
Dec 31, 2018 | $81.99 M |
-27.73%
|
Dec 29, 2017 | $0.11 B |
-23.02%
|
Dec 30, 2016 | $0.15 B |
-71.20%
|
Dec 31, 2015 | $0.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Market Cap | = | SYBX Stock Price | * | SYBX Shares Outstanding |
= | $1.43 | * | 11.70 M | |
= | $16.73 M |